Torthaí cuardaigh - Igor Smolenov

  • 1 - 20 toradh as 20 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice

    Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice de réir Sue Ann Costa Clemens, Lily Yin Weckx, Eveline Pı́polo Milan, Igor Smolenov, Ralf Clemens

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Preterm European Infants

    Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Preterm European Infants de réir Félix Omeñaca, J Sarlangue, Leszek Szenborn, Marta Nogueira, P.V. Suryakiran, Igor Smolenov, Htay Htay Han

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Horizontal transmission of a human rotavirus vaccine strain—A randomized, placebo-controlled study in twins

    Horizontal transmission of a human rotavirus vaccine strain—A randomized, placebo-controlled study in twins de réir Luis Rivera, Lourdes Peña, Isabelle Stainier, Paul Gillard, Brigitte Cheuvart, Igor Smolenov, Eduardo Ortega-Barrı́a, Htay Htay Han

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults

    Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults de réir Brandon Essink, Carlos Fierro, Jeffrey B. Rosen, Amparo L. Figueroa, Bin Zhang, Carole Verhoeven, Jonathan M. Edelman, Igor Smolenov

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine

    Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine de réir Peter Richmond, Lara Hatchuel, Filippo Pacciarini, Branda Hu, Igor Smolenov, Ping Li, Peng Liang, Htay Htay Han, Joshua G. Liang, Ralf Clemens

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults

    Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults de réir Allison August, Christine A. Shaw, Heather Lee, Conor Knightly, Shiva Kalidindia, Laurence Chu, Brandon Essink, William Seger, Tal Zaks, Igor Smolenov, Lori Panther

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    A first-in-human evaluation of the safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19 in healthy adults; a phase 1, randomised, double-blind, placebo-controlled trial

    A first-in-human evaluation of the safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19 in healthy adults; a... de réir Peter Richmond, Lara Hatchuel, Min Dong, Brenda Ma, Branda Hu, Igor Smolenov, Ping Li, Peng Liang, Htay Htay Han, Joshua G. Liang, Ralf Clemens

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán
    Pré-impressão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

    Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial de réir Peter Richmond, Lara Hatchuel, Min Dong, Brenda Ma, Branda Hu, Igor Smolenov, Ping Li, Peng Liang, Htay Htay Han, Joshua G. Liang, Ralf Clemens

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, observer-blinded, controlled, phase 2 study

    Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, observer-blinded, controlled, phase 2 study de réir Sue Ann Costa Clemens, Eveline Pı́polo Milan, Eduardo Sprinz, José Cerbino Neto, Filippo Pacciarini, Ping Li, Huiling Chen, Igor Smolenov, Andrew J. Pollard, Ralf Clemens

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Pré-impressão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Homologous and Heterologous Boosting of the Chadox1-S1-S COVID-19 Vaccine With the SCB-2019 Vaccine Candidate: A Randomized, Controlled, Phase 2 Study

    Homologous and Heterologous Boosting of the Chadox1-S1-S COVID-19 Vaccine With the SCB-2019 Vaccine Candidate: A Randomized, Controlled, Phase 2 Study de réir Sue Ann Costa Clemens, Eveline Pı́polo Milan, Eduardo Sprinz, José Cerbino Neto, Filippo Pacciarini, Ping Li, Huiling Chen, Igor Smolenov, Andrew J. Pollard, Ralf Clemens

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Heterologous boosting of neutralizing activity against Delta and Omicron SARS-CoV-2 variants in CoronaVac-primed adults; a randomized study with SCB-2019 vaccine

    Heterologous boosting of neutralizing activity against Delta and Omicron SARS-CoV-2 variants in CoronaVac-primed adults; a randomized study with SCB-2019 vaccine de réir Camilo C. Roa, Mari Rose A de Los Reyes, Eric Plennevaux, Igor Smolenov, Branda Hu, Faith Gao, Hannalyn Ilagan, Donna M. Ambrosino, George R. Siber, Ralf Clemens

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Pré-impressão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines

    SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines de réir Camilo C. Roa, Mari Rose A de Los Reyes, Eric Plennevaux, Igor Smolenov, Branda Hu, Faith Gao, Hannalyn Ilagan, Donna M. Ambrosino, George R. Siber, Ralf Clemens, Htay Htay Han

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

    mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials de réir Robert Feldman, Rainard Fuhr, Igor Smolenov, Amilcar Ribeiro, Lori Panther, Michael Watson, Joseph J. Senn, Mike Smith, Örn Almarsson, Hari Pujar, Michael E. Laska, James D. Thompson, Tal Zaks, Giuseppe Ciaramella

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike

    Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike de réir Wonyeong Jung, Dansu Yuan, Benjamin P. Kellman, Isabela Garrido da Silva Gonzalez, Ralf Clemens, Eveline Pı́polo Milan, Eduardo Sprinz, José Cerbino-Neto, Igor Smolenov, Galit Alter, Ryan P. McNamara, Sue Ann Costa Clemens

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Immunogenicity of an Oral Polio Vaccine is Unaffected when Co-Administered with a Human Rotavirus Vaccine RIX4414 (Rotarix™) in Latin America

    Immunogenicity of an Oral Polio Vaccine is Unaffected when Co-Administered with a Human Rotavirus Vaccine RIX4414 (Rotarix™) in Latin America de réir Pío López, Héctor Abate, Tirza De León, Miguel Tregnaghi, Alejandra Valencia, Themis Reverbel da Silveira, Luis Rivera, Doris Maribel Rivera-Medina, S.A. Gonzalez, Eduardo Ortega-Barrı́a, José María Casellas, P.V. Suryakiran, Igor Smolenov, Hongying Han

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Oral Human Rotavirus Vaccine RIX4414(Rotarix™) Co-administered with Routine EPI Vaccinations Including Oral Polio Vaccine(OPV) Is Highly Efficacious in Latin-America

    Oral Human Rotavirus Vaccine RIX4414(Rotarix™) Co-administered with Routine EPI Vaccinations Including Oral Polio Vaccine(OPV) Is Highly Efficacious in Latin-America de réir Miguel Tregnaghi, Pío López, Tirza De León, Héctor Abate, Alejandra Valencia, S.A. Gonzalez, Themis Reverbel da Silveira, Luis Rivera, Doris Maribel Rivera-Medina, Eduardo Ortega-Barrı́a, José María Casellas, P.V. Suryakiran, Igor Smolenov, H.H. Han

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: A randomized clinical trial in an Asian population

    Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: A randomized clinical trial in an Asian population de réir Kong Boo Phua, Fong Seng Lim, YL Lau, E. Anthony S. Nelson, Li‐Min Huang, Seng Hock Quak, Bee Wah Lee, L.J. van Doorn, Yee Leong Teoh, Haïwen Tang, P.V. Suryakiran, Igor Smolenov, Hans L. Bock, Htay Htay Han

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

    A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults de réir Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin, Nicholas Farinola, Radha Railkar, Xin Cao, Wen Liu, Jeffrey R. Sachs, Christine J. Swenson, Heather Lee, Kara S. Cox, Daniel S. Spellman, Colleen J. Winstead, Igor Smolenov, Eseng Lai, Tal Zaks, Amy S. Espeseth, Lori Panther

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

    Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials de réir Nhân Thị Hồ, Steven G. Hughes, Van Thanh Ta, Phan Trong Lan, Quyết Đỗ, Thượng Vũ Nguyễn, Anh Thị Văn Phạm, Mai Thị Ngọc Đặng, Lượng Viết Nguyễn, Quang Vinh Trịnh, Hung N. Pham, Men V. Chu, Toàn Trọng Nguyễn, Quang Chấn Lương, Vy Thị Tường Lê, Thang Toan Nguyen, Lý-Thị-Lê Trần, Anh Thi Van Luu, Anh Ngọc Nguyễn, Thi-Hong-Nhung Nguyen, Hai-Son Vu, Jonathan M. Edelman, Suezanne E. Parker, Brian M. Sullivan, Sean B. Sullivan, Qian Ruan, Brenda Clemente, Brian T. Luk, Kelly Lindert, Dina Berdieva, Kat Murphy, Rose E. Sekulovich, Benjamin N. Greener, Igor Smolenov, Pad Chivukula, Vân Thu Nguyễn, Xuan‐Hung Nguyen

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

    Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial de réir Lulu Bravo, Igor Smolenov, Htay Htay Han, Ping Li, Romana Hosain, Frank W. Rockhold, Sue Ann Costa Clemens, Camilo C. Roa, Charissa Borja-Tabora, Antoinette Quinsaat, Pío López, Eduardo López‐Medina, L Brochado, Eder Hernández, Humberto Reynales, Tatiana Medina, Hector Velásquez, Leonardo Bautista Toloza, Edith Johana Rodriguez, Dora I. Molina, Camilo Alejandro Corchuelo Rodríguez, Eduardo Sprinz, José Cerbino-Neto, Kléber Giovanni Luz, Alexandre Vargas Schwarzbold, Maria Sanali Moura de Oliveira Paiva, Josefina Carlos, May Emmeline B. Montellano, Mari Rose A de Los Reyes, Charles Yu, Edison Alberto, Mario Panaligan, Milagros Salvani-Bautista, Erik Buntinx, Maya Hites, Jean‐Benoît Martinot, Qasim Bhorat, Aysha Badat, Carmen Baccarini, Branda Hu, Jaco Jurgens, Jan Engelbrecht, Donna M. Ambrosino, Peter Richmond, George R. Siber, Joshua G. Liang, Ralf Clemens

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: